C4 Therapeutics Inc.
(CCCC)
undefined
undefined%
At close: undefined
3.85
-1.14%
After-hours Jan 03, 2025, 04:13 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| PE Ratio | -2.12 | -2.28 | -17.23 | -21.51 | -32.13 | -23.99 |
| PS Ratio | 13.51 | 9.27 | 32.38 | 42.98 | 51.25 | 19.47 |
| PB Ratio | 1.14 | 1.00 | 3.81 | 5.08 | -9.79 | -4.73 |
| P/FCF Ratio | -2.58 | -2.59 | -16.8 | -21.01 | 20.19 | -19.16 |
| P/OCF Ratio | -2.63 | -2.72 | -17.05 | -21.21 | 19.70 | -22.2 |
| OCF/S Ratio | -5.15 | -3.41 | -1.9 | -2.03 | 2.60 | -0.88 |
| Debt / Equity Ratio | n/a | 0.06 | 0.11 | 0.08 | -0.12 | n/a |
| Quick Ratio | 6.34 | 7.82 | 6.36 | 8.69 | 2.88 | 5.16 |
| Current Ratio | 6.34 | 6.46 | 6.36 | 8.69 | 2.88 | 5.16 |
| Asset Turnover | 0.06 | 0.07 | 0.09 | 0.08 | 0.18 | 0.13 |
| Interest Coverage | -101.26 | -58.45 | -38.29 | -49.19 | n/a | n/a |
| Return on Equity (ROE) | -0.54 | -0.44 | -0.22 | -0.24 | 0.30 | 0.20 |
| Return on Assets (ROA) | -0.35 | -0.29 | -0.17 | -0.17 | -0.29 | -0.11 |
| Return on Capital (ROIC) | -0.42 | -0.34 | -0.18 | -0.17 | -0.42 | -0.13 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | -467.09% | 75.65% | 93.65% | -133.37% | -122.93% | -47.66% |
| Net Profit Margin | -638.34% | -406.8% | -187.92% | -199.83% | -159.48% | -81.14% |
| Pretax Profit Margin | -632.17% | -412.19% | -183.23% | -201.72% | -155.72% | -81.14% |
| Operating Profit Margin | -669.84% | -416.56% | -179.39% | -182.1% | -165.81% | -84.64% |
| FCF Margin | -522.96% | -358.36% | -192.73% | -204.55% | 253.80% | -101.58% |
| EBITDA Margin | -588.28% | -399.68% | -172.2% | -189.46% | -142.91% | -78.06% |